Genomic Surveillance of Third-Generation Cephalosporin-Resistant Klebsiella pneumoniae in Tunisian AMR Surveillance System Hospitals

This study utilized whole-genome sequencing of 322 isolates from three Tunisian hospitals to reveal a diverse population of third-generation cephalosporin-resistant *Klebsiella pneumoniae* dominated by ESBLs and specific carbapenemases, characterized by sustained ward-level transmission and the emerging convergence of hypervirulence markers, thereby highlighting the critical need for targeted infection control and routine genomic integration in national surveillance.

The Gist

Imagine the human body as a bustling city, and the bacteria Klebsiella pneumoniae as a group of troublemakers trying to break in. Usually, we have a powerful police force called antibiotics to stop them. But recently, these troublemakers have learned to wear "bulletproof vests" that make the standard police gear (specifically, a type of antibiotic called third-generation cephalosporins) useless. This is a growing crisis in Tunisia.

To understand how these "super-criminals" are operating, scientists in Tunisia decided to put on their detective hats and use a high-tech tool called Whole-Genome Sequencing (WGS). Think of WGS as reading the bacteria's entire "instruction manual" or "DNA fingerprint" to see exactly how they are built, how they hide, and how they move around.

Here is what the investigation revealed, broken down into simple stories:

1. The Suspects and the Crime Scene

The researchers looked at 322 samples taken from patients' blood and urine between 2018 and 2022 from three major hospitals in Tunis and Ben Arous.

• The Cast: Out of the samples, 286 were confirmed to be the specific bacteria they were hunting.
• The Variety: These bacteria weren't all clones of each other. They were like a diverse crowd of 68 different "families" (sublineages). While some families were unique to specific hospitals, others were "travelers" found in all three locations, suggesting they are moving around the country.

2. The Weapons in Their Arsenal

The bacteria carry special tools to defeat our medicine. The study found three main types of weapons:

• The "Shield" (ESBLs): About 77% of the bacteria had a shield called blaCTX-M-15. It's like a generic force field that blocks the most common antibiotics. This was the most popular weapon, found everywhere.
• The "Heavy Armor" (Carbapenemases): About 20% had even scarier armor that can break through the "last resort" antibiotics. This was mostly seen in one specific hospital (Hospital B) and within two specific bacterial families. It's like finding a tank in a neighborhood where everyone else only has bicycles.
• The "Special Ops" (Virulence): Some bacteria carry a "backpack" of extra tools (called ICEKp) that help them stick to walls and cause more damage. While most had the standard backpack, a small but growing number (about 9%) were carrying "super backpacks" that make them incredibly dangerous and sticky. These "super backpacks" are starting to mix with the "heavy armor" families, creating a terrifying hybrid threat.

3. The Trail of Evidence: How They Spread

One of the most important discoveries was how these bacteria move inside the hospitals.

• The Clusters: The DNA detective work found 24 distinct "cliques" or groups of bacteria that were almost identical. This proved that the bacteria weren't just appearing randomly; they were spreading from patient to patient within the same hospital.
• The Neighborhoods: These groups stayed within their own hospital (they didn't jump between the three hospitals studied), but they did spread across different wards (floors or departments) within that same building. It's like a rumor spreading through one office building but not jumping to the building next door.

4. The Big Picture: What Does This Mean?

The study tells us two critical things:

1. The Problem is Local but Persistent: The bacteria are spreading quietly within hospital wards, likely because infection control measures (like hand washing and cleaning) need to be stricter in specific areas.
2. The Threat is Evolving: We are seeing a dangerous trend where the "super backpacks" (hypervirulence) are starting to join forces with the "heavy armor" (resistance). If these two traits fully merge, we could face bacteria that are both incredibly hard to kill and incredibly good at causing severe disease.

The Takeaway

The researchers are saying, "We need to keep using our high-tech DNA detective tools." By reading the bacteria's instruction manuals, we can spot these outbreaks early, stop them from spreading between hospital rooms, and design better strategies to keep our "city" safe. It's a call to action to upgrade our surveillance system to stay one step ahead of these evolving troublemakers.

Technical Summary

Technical Summary: Genomic Surveillance of Third-Generation Cephalosporin-Resistant Klebsiella pneumoniae in Tunisia

1. Problem Statement

Third-generation cephalosporin (3GC)-resistant Klebsiella pneumoniae (3GCR-Kp) represents a critical public health threat in Tunisia. However, there is a significant lack of data regarding the specific circulating lineages, the genetic determinants of antimicrobial resistance (AMR), and the transmission dynamics of these pathogens within the country. Traditional surveillance methods are insufficient to capture the complexity of the population structure and the emergence of high-risk clones, necessitating a shift toward genomic-level analysis to inform infection prevention and control (IPC) strategies.

2. Methodology

The study leveraged the Tunisian AMR Surveillance System (TARSS) to conduct a comprehensive genomic epidemiology analysis.

• Study Design: A retrospective whole-genome sequencing (WGS) study of stored clinical isolates.
• Sample Collection: A balanced sample of 322 3GCR isolates was collected from blood and urine specimens between 2018 and 2022.
• Setting: Three sentinel hospitals located in Tunis and Ben Arous.
• Sequencing & Analysis: Isolates underwent WGS to characterize:
  • Resistance mechanisms (ESBLs, AmpC, carbapenemases).
  • Population structure (Sublineages/STs).
  • Virulence factors (ICEKp, hypervirulence markers).
  • Transmission clusters (using genomic distance thresholds to identify nosocomial spread).

3. Key Contributions

This study provides the first high-resolution genomic overview of 3GCR-Kp in Tunisia's surveillance system. Key contributions include:

• Validation of Surveillance: Demonstrating the feasibility and value of integrating WGS into national surveillance (TARSS) to monitor AMR.
• Lineage Mapping: Identifying the specific sublineages driving resistance and distinguishing between hospital-specific and globally disseminated clones.
• Transmission Dynamics: Quantifying the extent of ward-level nosocomial transmission that is often missed by phenotypic surveillance alone.
• Convergence Detection: Highlighting the emergence of "convergent" strains carrying both multidrug resistance and hypervirulence markers.

4. Key Results

• Isolate Characterization: Of the 322 sequenced isolates, 286 (89%) were confirmed as K. pneumoniae, representing 28.5% of all stored 3GCR isolates in the system.
• Population Structure: The population was highly diverse, comprising 68 distinct sublineages. While many were unique to specific hospitals, globally distributed sublineages (SL383, SL101, SL307, SL15) were detected across all sites.
• Resistance Mechanisms:
  • ESBLs: Detected in 77% of genomes. blaCTX-M-15 was dominant (65.4%), followed by blaCTX-M-14 (8%).
  • AmpC: Present in 9% of isolates.
  • Carbapenemases: Found in 19.6% of isolates, primarily blaOXA-48 (14.7%), blaNDM-5 (4.5%), and blaNDM-1 (3.8%). Notably, carbapenemase production was concentrated in Hospital B (41.7%), specifically within sublineages SL147 and SL383.
• Transmission Clusters: Despite sequencing less than one-third of unique infections, the study identified 24 probable nosocomial transmission clusters involving 64 isolates. These clusters were hospital-specific but often spanned multiple wards within the same facility.
• Virulence Factors:
  • The yersiniabactin-encoding ICEKp locus was common (48.6%).
  • Hypervirulence markers (aerobactin, salmochelin, hypermucoidy) were rare overall (8.7%) but showed an increasing trend over time.
  • These hypervirulent traits were predominantly found in sublineages known for ESBL/hypervirulence convergence (SL147, SL101, SL383), suggesting international dissemination of these high-risk clones.

5. Significance and Implications

The findings underscore a sustained pattern of ward-level nosocomial transmission of 3GCR-Kp in Tunisian hospitals, indicating that current infection control measures may be insufficient to contain local spread. The study reveals significant heterogeneity in resistance burdens between hospitals, particularly the high prevalence of carbapenemases in Hospital B, which requires targeted, site-specific interventions.

Furthermore, the detection of convergent strains (ESBL + hypervirulence) signals a potential future threat of highly virulent, drug-resistant outbreaks. The authors conclude that routine integration of WGS into TARSS is essential for real-time monitoring, early detection of transmission clusters, and the formulation of evidence-based public health policies to combat AMR in Tunisia.